Targeting myeloid-derived suppressor cells in combination with tumor cell vaccination predicts anti-tumor immunity and breast cancer dormancy: an in silico experiment

Among the different breast cancer subsets, triple-negative breast cancer (TNBC) has the worst prognosis and limited options for targeted therapies. Immunotherapies are emerging as novel treatment opportunities for TNBC. However, the surging immune response elicited by immunotherapies to eradicate ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Mehdizadeh, Reza, Shariatpanahi, Seyed Peyman, Goliaei, Bahram, Rüegg, Curzio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10090155/
https://www.ncbi.nlm.nih.gov/pubmed/37041172
http://dx.doi.org/10.1038/s41598-023-32554-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10090155/
https://www.ncbi.nlm.nih.gov/pubmed/37041172
http://dx.doi.org/10.1038/s41598-023-32554-z

Ejemplares similares